Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...

Recall applies to sets manufactured before April 2017; Medtronic is replacing old sets that have a risk of insulin over-delivery

Lilly’s Humalog Junior KwikPen offers 0.5 unit dose increments in prefilled, disposable device – a win for highly insulin sensitive users

Key takeaways from the American Heart Association’s March 2017 conference in Portland, OR

How Adam Brown learned to make low-carb food tasty, doable, portable, and fun. Plus, cool new diabetes food experiments he's been testing!

The FDA officially approves the new, expanded indication for people with type 2 diabetes

New apps and software updates from mySugr, Insulia, One Drop, as well as food and weight loss apps

The most popular diabetes app in the world, mySugr offers coaching and tools to track blood sugar, medications, exercise, and “makes diabetes suck less”

A real-world trial in 3,000+ participants currently enrolling participants with type 2 diabetes

CANVAS study presented at ADA 2017 highlights heart and kidney protection for type 2 diabetes drug Invokana, and questions persist over an increased risk of amputations

Jim Hirsch tells the story of how Type 1 Team Texas emerged to meet the diabetes community's needs in the face of the hurricane

Implanted sensor with on-body transmitter lasts more than 12x longer than other CGMs; launch expected in Europe in late 2017

ADA and AADE publish guidelines for healthcare professionals on word choices that empower people with diabetes

CVD-REAL study showed SGLT-2 inhibitors reduce the risk of hospitalization for heart failure in over 300,000 people with type 2 diabetes

Breaking down employer-based health insurance, employee health benefits, and employee rights for people with diabetes

CGMs with an insulin-dosing claim, like Dexcom’s G5, finally have a path to Medicare reimbursement; possible coverage in 2018 or earlier

By Maeve Serino and Adam Brown Learn about what’s new and what’s coming soon in Smart Pens, automated insulin delivery, pumps, and more Diabetes technology moves fast,...

Amalgam Rx receives FDA clearance for basal insulin dosing app, iSage Rx; available with a prescription to adjust Lantus, Levemir, Toujeo, Tresiba, and Basaglar

How to get cheaper drugs, find discount programs, get free care in clinical trials, and more

Despite neutral heart outcome study results, the FDA added a warning for those at risk of heart failure